381 related articles for article (PubMed ID: 9340503)
1. A comparison of reteplase with alteplase for acute myocardial infarction.
Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO III) Investigators
N Engl J Med; 1997 Oct; 337(16):1118-23. PubMed ID: 9340503
[TBL] [Abstract][Full Text] [Related]
2. Randomized comparison of coronary thrombolysis achieved with double-bolus reteplase (recombinant plasminogen activator) and front-loaded, accelerated alteplase (recombinant tissue plasminogen activator) in patients with acute myocardial infarction. The RAPID II Investigators.
Bode C; Smalling RW; Berg G; Burnett C; Lorch G; Kalbfleisch JM; Chernoff R; Christie LG; Feldman RL; Seals AA; Weaver WD
Circulation; 1996 Sep; 94(5):891-8. PubMed ID: 8790022
[TBL] [Abstract][Full Text] [Related]
3. Randomised, double-blind comparison of reteplase double-bolus administration with streptokinase in acute myocardial infarction (INJECT): trial to investigate equivalence. International Joint Efficacy Comparison of Thrombolytics.
Lancet; 1995 Aug; 346(8971):329-36. PubMed ID: 7623530
[TBL] [Abstract][Full Text] [Related]
4. Patency trials with reteplase (r-PA): what do they tell us?
Bode C; Nordt TK; Peter K; Smalling RW; Runge MS; Kübler W
Am J Cardiol; 1996 Dec; 78(12A):16-9. PubMed ID: 8990406
[TBL] [Abstract][Full Text] [Related]
5. A comparison of continuous infusion of alteplase with double-bolus administration for acute myocardial infarction.
Continuous Infusion versus Double-Bolus Administration of Alteplase (COBALT) Investigators
N Engl J Med; 1997 Oct; 337(16):1124-30. PubMed ID: 9340504
[TBL] [Abstract][Full Text] [Related]
6. Reteplase. A review of its pharmacological properties and clinical efficacy in the management of acute myocardial infarction.
Noble S; McTavish D
Drugs; 1996 Oct; 52(4):589-605. PubMed ID: 8891469
[TBL] [Abstract][Full Text] [Related]
7. Comparisons of characteristics and outcomes among women and men with acute myocardial infarction treated with thrombolytic therapy. GUSTO-I investigators.
Weaver WD; White HD; Wilcox RG; Aylward PE; Morris D; Guerci A; Ohman EM; Barbash GI; Betriu A; Sadowski Z; Topol EJ; Califf RM
JAMA; 1996 Mar; 275(10):777-82. PubMed ID: 8598594
[TBL] [Abstract][Full Text] [Related]
8. A clinical trial comparing primary coronary angioplasty with tissue plasminogen activator for acute myocardial infarction.
Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coronary Syndromes (GUSTO IIb) Angioplasty Substudy Investigators
N Engl J Med; 1997 Jun; 336(23):1621-8. PubMed ID: 9173270
[TBL] [Abstract][Full Text] [Related]
9. Clinical trials in thrombolytic therapy: what do they tell us? INJECT 6-month outcomes data.
Wilcox RG
Am J Cardiol; 1996 Dec; 78(12A):20-3. PubMed ID: 8990407
[TBL] [Abstract][Full Text] [Related]
10. The role of thrombolytic drugs in the management of myocardial infarction. Comparative clinical trials.
Weaver WD
Eur Heart J; 1996 Dec; 17 Suppl F():9-15. PubMed ID: 8960443
[TBL] [Abstract][Full Text] [Related]
11. Reteplase: a new thrombolytic for the treatment of acute myocardial infarction.
Wooster MB; Luzier AB
Ann Pharmacother; 1999 Mar; 33(3):318-24. PubMed ID: 10200858
[TBL] [Abstract][Full Text] [Related]
12. Spotlight on reteplase in thrombotic occlusive disorders.
Simpson D; Siddiqui MA; Scott LJ; Hilleman DE
BioDrugs; 2007; 21(1):65-8. PubMed ID: 17263591
[TBL] [Abstract][Full Text] [Related]
13. Reteplase: new preparation. Minimal value: bolus versus infusion.
Prescrire Int; 1998 Jun; 7(35):73-4. PubMed ID: 10342921
[TBL] [Abstract][Full Text] [Related]
14. Results of the RAPID 1 and RAPID 2 thrombolytic trials in acute myocardial infarction.
Weaver WD
Eur Heart J; 1996 Sep; 17 Suppl E():14-20. PubMed ID: 11823998
[TBL] [Abstract][Full Text] [Related]
15. Reteplase: a review of its use in the management of thrombotic occlusive disorders.
Simpson D; Siddiqui MA; Scott LJ; Hilleman DE
Am J Cardiovasc Drugs; 2006; 6(4):265-85. PubMed ID: 16913828
[TBL] [Abstract][Full Text] [Related]
16. More rapid, complete, and stable coronary thrombolysis with bolus administration of reteplase compared with alteplase infusion in acute myocardial infarction. RAPID Investigators.
Smalling RW; Bode C; Kalbfleisch J; Sen S; Limbourg P; Forycki F; Habib G; Feldman R; Hohnloser S; Seals A
Circulation; 1995 Jun; 91(11):2725-32. PubMed ID: 7758177
[TBL] [Abstract][Full Text] [Related]
17. Reteplase versus Alteplase for Acute Ischemic Stroke.
Li S; Gu HQ; Li H; Wang X; Jin A; Guo S; Lu G; Che F; Wang W; Wei Y; Wang Y; Li Z; Meng X; Zhao X; Liu L; Wang Y;
N Engl J Med; 2024 Jun; 390(24):2264-2273. PubMed ID: 38884332
[TBL] [Abstract][Full Text] [Related]
18. ST-segment resolution 60 minutes after combination treatment of abciximab with reteplase or reteplase alone for acute myocardial infarction (30-day mortality results from the resolution of ST-segment after reperfusion therapy substudy).
Cura FA; Roffi M; Pasca N; Wolski KE; Lincoff AM; Topol EJ; Lauer MS;
Am J Cardiol; 2004 Oct; 94(7):859-63. PubMed ID: 15464665
[TBL] [Abstract][Full Text] [Related]
19. Frequency and clinical outcome of cardiogenic shock during acute myocardial infarction among patients receiving reteplase or alteplase. Results from GUSTO-III. Global Use of Strategies to Open Occluded Coronary Arteries.
Hasdai D; Holmes DR; Topol EJ; Berger PB; Criger DA; Hochman JS; Bates ER; Vahanian A; Armstrong PW; Wilcox R; Ohman EM; Califf RM
Eur Heart J; 1999 Jan; 20(2):128-35. PubMed ID: 10099909
[TBL] [Abstract][Full Text] [Related]
20. Optimal thrombolytic strategies for acute myocardial infarction--bolus administration.
McMechan SR; Adgey AA
QJM; 1998 Nov; 91(11):719-25. PubMed ID: 10024933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
